Cynosure and Lutronic announce merger to create new commercial presence

Cynosure and Hahn & Company, which has recently acquired Lutronic, announced that they have entered into a definitive merger agreement for a strategic combination of Cynosure and Lutronic.

Both Cynosure and Lutronic are providers of energy-based medical aesthetic treatment systems and related technologies. The transaction is expected to close in the first quarter of 2024.

The collaboration will create a diversified, innovative product portfolio and a commercial presence in over 130 countries. The combined company will offer customers and patients a broader product and consumables suite, a depth of related clinical training and services, expanded research and development capabilities, an enhanced geographic footprint to serve more customers around the world and a reinforced supply chain to ensure seamless continuity of products and services.

"The strategic combination will create a combined company with the resources, product portfolio and expertise that will benefit our customers, partners and employees,” commented Nadav Tomer, chief executive of Cynosure:  We are thrilled that Cynosure is partnering with Lutronic as we believe this will create a distinct opportunity to combine two strong global players in energy-based medical device technology for aesthetics."

Haelyung Hwang, founder and chief executive of Lutronic said, "Partnering with Cynosure is a meaningful and transformational next step in diversifying our portfolio and scaling our company. This strategic combination furthers Lutronic's mission to drive innovation and provide superior products and customer service to aesthetics providers around the world. Cynosure's innovative medical device technology, commercial infrastructure and best-in-class brand-building capabilities will broaden our product line and customer base globally.